TEN years have now elapsed since the isolation of progesterone. Born, the embrvologist, was the first to conceive the idea of the function of the corpus luteum. He postulated that the corpus luteum had an important function in pregnancy, since it occurred only in mammals and reached maximum development only during pregnancy. He did not live to prove his hypothesis, but Ludwig Fraenkel, in 1903, showed that removal of the corpora lutea in the first few days of pregnancy in the rabbit caused the embryos to disappear. He was unable to determine what happened to the embryos and it was not until 1928 that Corner showed that they survived and reached the uterus on the fourth day. There they shrivelled and disappeared because the endometrium had not been prepared for their arrival by the corpus luteum hormone.
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Fraenkel's work was followed in 1907 by the discoverv by Leo Loeb that the corpus luteum specifically alters the uterus of the guinea-pig so that implantation of the embryo becomes possible. In the guinea-pig no histological difference following the action of the corpus luteum is demonstrable but mechanical injurv of the endometrium or the presence of the embryo results in the production of a deciduoma. Thus he found that in the guinea-pig deciduomata could onlv be produced during the luteal phase of the cycle and that removal of the corpus luteum prevented their formation.
In 1910 Bouin and Ancel began experiments which in the light of the present knowledge proved to be the most significant of all. They found that in rabbits in which ovulation had been induced by sterile mating, the uterus underwent very marked changes as the corpora lutea developed. It became congested and its epithelium grew rapidly, producing a very elaborate endometrium which was interpreted as being necessary for implantation. This change, later designated by Corner as progestation proliferation, did not occur if the corpora were removed. These classical observations established the corpus luteum as an endocrine giand, the function of which was to prepare the uterus for implantation of the embrvo. These discoveries were rapidly followed by attempts to isolate the active substance, and in 1915 Herrmann proved that lipoid extraction of the corpus luteum and of the placenta contained an active substance which induced growth and congestion of the uterus and in some instances progestational proliferation of the endometrium. He, however, did not fully distinguish between the growth of the uterus and the change of the endometrium.
These experiments, with their faulty interpretation, delayed further knowledge until years later when it became apparent that the oestrogenic hormone was responsible for the Proceedings of -the Royal Society of Medicine 36 growth changes in the uterus and the action of the corpus luteum hormone was specific on the endometrium. In 1928, Corner repeated the earlier work and found that extracts of the placenta would usually produce uterine growth, whereas extracts of the corpus luteum would only produce progestational proliferation of the endometrium. It was also discovered that the action of the corpus luteum hormone did not appear to be regular. Analysis of results showed that this irregularity was due to the test animal. Regular results could always be produced if sexually mature castrated animals were used, and the result was not seen in immature females.
This observation had two vcry important results. In the first place a method of bioassay was possible, a fact of outstanding importance, as bv its means was made possible the isolation later of the pure secretion progesterone. Secondly it led to the discovery that the corptus luteum hormone could only exert its, action on a uterus previously sensitized by oestrogenic substance, and this was later demonstrated conclusively in animal experimentation and led to another method of bio-assay, the Clauberg method.
Many workers then proceeded with the search for the active substance, and in 1931 and 1932 crystalline substances were isolated with all the knlowvn activities of the corpus luteum. The methods, however, were long and tedious and the vields poor. It is doubtful whether in actual fact these earlier products were the pure substance, and the demonstration of pure progesterone was really made in 1934.
Two compounds were isolated which were apparently identical but found to have different melting points. They both had the same degree of activity and Nvere shown to be different crystalline forms of the same substance and depended on the method of crystallization. These are spoken of as alpha and beta progesterone, and although it is still said sometimes that one is more potent than the other, there is no evidence on which this can be based. Following its isolation its chemical structure was proved almost simultaneously by Butenandt and bv Fernholz and the hormone synthesized, the synthetic product being identical in all respects with the natural product. Additional proof was also found by another method. MVarrian in 1929 whilst working on the cestrins in urine in women discovered an inactive alcoholic substance in the urine of pregnant women. This substance was found by Butenandt in 1930 to be pregnanediol. The close similarity of this structure to progesterone led to the surmise that this substance might be an excretion product of progesterone, particularly in view of the fact that Marrian only found this substance in pregancy urine. Butenandt also showed that this pregnanediol could be converted by chemical means back to progesterone. Following the discovery of the structure of progesterone and of pregnanediol, large numbers of allied substances were prepared, yet there remained only one which could produce the effects of the corpus luteum, namely progesterone. It appears to be a remarkably specific hormone.
The name progesterone has generallv been adopted for the nure substance, and one international unit of progesterone is defined as the specific progestational activity of 1 mg. of the international standard preparation of beta progesterone, and 1 Cornier-Allen unit is approximately equal to 1 mg. of either alpha or beta progesterone.
In 1936 Venning and Browne demonstrated that pregnanediol was not excreted as such in the urine but as a glucuronide, and that the complex sodium pregnanediol glucuronide could be extracted quantitatively from urine. Following this work it was discovered that this compound was present in the urine of women during the luteal phase of the cycle and during pregnancy, and was absent at all other times. The quantity excreted is considerable. In pregnancv there is a gradual increase in amount from the third month until the eighth month when between 70 and 80 mg. is excreted in twentyfour hours. It disappears within twenty-four hours of delivery. During the progestational phase of the menstrual cycle pregnanediol is excreted in variable amounts. There appears to be a wide range of normality, from 3 to 60 mg. These discoveries led to strong presumptive evidence that this compound was the excretory product of progesterone and final proof was found in that progesterone administered artificially could be recovered in a reasonable yieid as pregnanediol glucuronide from the urine. It is stated that conversion is immediate and maximal during the luteal phase of the cycle or early pregnancy. These conditions are not, however, necessary, for I have shown that the conversion of injected progesterone will occur at any time in the cycle, that it will occur in the absence of the uterus and in the absence of the ovaries, and moreover, as we shall see later in some pathological conditions, there appears to be facilitation of this conversion after a passage of time. In addition the administration of progesterone to healthy men is followed by the excretion of pregnanediol. I lhave also shown that this conversion will also occur in castrate men. This method of excretion is peculiar to human beings. It does not occur even in monkeys, and moreover even after the injection of 1 g. of progesterone into thle pregnant monkey there is nio pregnanediol demonstrable in the urine.
From the results published elsewhere and from our own results it would appear that approximately half of the progesterone elaborated by the corpus luteum or given by injection appears in the urine as this complex. It is possible that more appears in an altered form.
Applying this knowvedge to disease we began to investigate the condition metropathia hbemorrhaejca. Investigations of untreated patients with this condition over the course of many months showed complete absence of the excretion of pregnanediol. We therefore considered that it might be possible in such patients to establish an artificial cycle of menstruation by substitution therapy with progesterone. To begin with we began by administering four doses given on alternate days of 20 mg. of progesterone. Following such therapy, usually on the second to fourth day, bleeding began from the uterus, or intensification of previous haemorrhage. This bleeding lasted from four to seven days and then spontaneouslv ceased. If no further treatment was administered after a variable interval of amenorrhcea the condition usually relapsed, though in a few instances regular menstruation occturred from one to three periods. So frequent, however, was complete relapse that we decided to continue the treatment, designing the injections to produce as nearly as possible a regular cycle, but gradually diminishing the dose of progesterone. In this way it has proved possible to keep such patients well for periods up to seven vears, which is our longest period of observation, and the dose requiired at thie end of such time is as a rule 5 to 10 mg. each month. At the end of each six regular bleedings we stop treatment to see whether the patient will continue normally without further treatment and in a number this proves to be the case. In others, however, the condition relapses, usually after twvo to three months amenorrhoea. In some we have been fortunate in that they have become pregnant, the pregnancv has been normal and the disease has not reappeared after the pregnancy.
We have investigated the behaviour of such patients to progesterone and we have followed the metabolism of progesterone in such patients. We were sturprised to discover that following the total dose of 80 mg. of progesterone we were unable to recover any pregnanediol from the urine. By continuing, however, we found that by the third treatment as a rule some pregnanediol would apnear, and with subsequent treatments pregnanediol appeared in the normal quantity. This has been a regular finding with this disease and we have no explanation as to why this should be so. It would appear, therefore, that one of the features of this disease is the inability to deal with progesterone normally but that this disability is removed by substitution therapy.
More recently a substance, anhydrohydroxy-progesterone, has been discovered which has progestational activity when administered bv mouth, but this activity appears to be about one-tenth weight for weight of injected progesterone. For obvious reasons it would be a great advantage if we could substitute this substance for progesterone, and I have, therefore, compared treatment of metropathia haemorrhagica with progesterone and anhydrohydroxy-progesterone. In order to compare the results I first used ten times the quantity by mouth, administering 800 mg. over the course of eight days. At first it appeared to work well. The hiemorrhage usually appeared up to five days following cessation of therapy and this usually went well for several months, but at the end of such a period the condition frequently relapsed and progesterone had to be used again. By varying the dosage I found that the effect could be produced just as well with half the dosage and finally by a quarter the dosage, and the relapse rate was no greater with the small than the high dosage. In an endeavour to see whether even at ten times the dose of progesterone the dose was still inadequate I doubled it and gave a course of 1,600 mg. but even in this very large dose there was still a high relapse rate. There are a few patients who have been kept well for up to three yeaN. but it appears that slightly less than 20% of such patients can be kept permanently well by substitution therapy with this substance.
Examination of the endometrium has shown that by adequate dosagc with progesterone, secretory endometrium is produced, but so far even with the very high dosaae of anhydrohydroxy-progesterone full conversion of the endometrium has not been seen. In view of the experimental findings that oxstrogen is necessary to prepare and hold the uterus for the action of progesterone, I have added small and large doses of cestrogen at the same time as the administration of anhydrohydroxv-progesterone but it did not appear to make any difference to the results, and the endometrium still remained unconverted.
